Sana Biotechnology

IPO

Engineered cells as medicines

Sana Biotechnology is a biotech company in Seattle, United States, founded in 2018. It has raised $1.4B across 5 rounds, most recently an $821.0M Series D in June 2020.

Employees
201–500
Founded
2018
Business Model
B2B
Website
sana.com
Total Funding
$1.4B
Last Round
$821.0M Series DJun 2020
Rounds
5
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 7 investors for this company. to use credits for reveals, or explore the API.

About

Sana Biotechnology is focused on creating engineered cells as medicines to repair and control genes or replace damaged cells, targeting diseases like diabetes, B-cell cancers, and autoimmune disorders. With operations in Seattle, Cambridge, and South San Francisco, Sana leverages expertise in cell and gene therapy to develop curative therapies.

Funding & Exit History

Data from Indexed.vcUpdated
IPOFeb 2021
$587.5M

5 more events

  • Series D20205 investors
  • Series B2019
  • Series A2018

Funding: Seed through Series D. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×3
  • Cloud/Infrastructure ×1
  • Frontend ×1
  • Productivity & Collaboration ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech
Corporate RoundTotal funding$2.3BJun 2018
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech
ConvertibleTotal funding$1.8BApr 2018
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sana Biotechnology on Indexed.vc
<a href="https://indexed.vc/companies/sana-biotechnology"><img src="https://indexed.vc/api/badge/company/sana-biotechnology" alt="Sana Biotechnology on Indexed.vc" width="260" height="76" /></a>